Compounds > p-hydroxyamphetamine

p-hydroxyamphetamine and ritobegron

p-hydroxyamphetamine has been researched along with ritobegron in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Homma, Y; Igawa, Y; Michel, MC; Nishizawa, O; Schneider, T; Tatemichi, S; Yamazaki, Y1
Hoyano, Y; Kusama, H; Maruyama, I; Maruyama, K; Tatemichi, S; Yamazaki, Y; Yonekubo, S1
Abe, Y; Endo, T; Kobayashi, M; Murakami, M; Ota, E1
Abe, Y; Endo, T; Harada, H; Kanazawa, T; Kanbe, H; Kobayashi, M; Kojima, Y; Murakami, M; Ota, E1
Abe, Y; Endo, T; Furihata, T; Kanazawa, T; Kobayashi, M; Nakano, Y1

Trials

1 trial(s) available for p-hydroxyamphetamine and ritobegron

ArticleYear
Investigation of Drug-Drug Interactions Between Ritobegron, a Selective β3 -Adrenoceptor Agonist, With Probenecid in Healthy Men.
    Clinical pharmacology in drug development, 2016, Volume: 5, Issue:3

    Topics: Acetates; Adrenergic beta-3 Receptor Agonists; Adult; Area Under Curve; Cross-Over Studies; Drug Interactions; Half-Life; Humans; Male; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; p-Hydroxyamphetamine; Probenecid; Young Adult

2016

Other Studies

4 other study(ies) available for p-hydroxyamphetamine and ritobegron

ArticleYear
Functional investigation of β-adrenoceptors in human isolated detrusor focusing on the novel selective β3-adrenoceptor agonist KUC-7322.
    Naunyn-Schmiedeberg's archives of pharmacology, 2012, Volume: 385, Issue:8

    Topics: Acetates; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Carbachol; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Female; Humans; Male; Muscarinic Agonists; Muscarinic Antagonists; Muscle Contraction; Muscle Relaxation; p-Hydroxyamphetamine; Parasympatholytics; Receptors, Adrenergic, beta; Urinary Bladder; Urinary Bladder Neoplasms

2012
Effects of ritobegron (KUC-7483), a novel β3-adrenoceptor agonist, on both rat bladder function following partial bladder outlet obstruction and on rat salivary secretion: a comparison with the effects of tolterodine.
    Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 2012, Volume: 48, Issue:5-6

    Topics: Acetates; Adrenergic beta-3 Receptor Agonists; Animals; Benzhydryl Compounds; Cresols; Female; Male; Muscarinic Antagonists; p-Hydroxyamphetamine; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Saliva; Time Factors; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Neck Obstruction

2012
Absorption, disposition, metabolism, and excretion of ritobegron (KUC-7483), a novel selective β3-adrenoceptor agonist, in rats.
    Die Pharmazie, 2014, Volume: 69, Issue:12

    Topics: Acetates; Adrenergic beta-3 Receptor Agonists; Animals; Area Under Curve; Bile; Biotransformation; Feces; In Vitro Techniques; Intestinal Absorption; Male; p-Hydroxyamphetamine; Protein Binding; Rats; Rats, Sprague-Dawley; Tissue Distribution; Urinary Bladder, Overactive

2014
Species differences in the metabolism of ritobegron in vitro and assessment of potential interactions with transporters and cytochrome P450 enzymes.
    Die Pharmazie, 2015, Volume: 70, Issue:1

    Topics: Acetates; Adrenergic beta-3 Receptor Agonists; Animals; Carrier Proteins; Cytochrome P-450 Enzyme System; Dogs; Drug Interactions; Enzyme Inhibitors; Haplorhini; Humans; In Vitro Techniques; Microsomes, Liver; p-Hydroxyamphetamine; Rats; Species Specificity; Subcellular Fractions

2015